Literature DB >> 10084993

Immunity to Chlamydia trachomatis mouse pneumonitis induced by vaccination with live organisms correlates with early granulocyte-macrophage colony-stimulating factor and interleukin-12 production and with dendritic cell-like maturation.

D Zhang1, X Yang, H Lu, G Zhong, R C Brunham.   

Abstract

As is true for other intracellular pathogens, immunization with live Chlamydia trachomatis generally induces stronger protective immunity than does immunization with inactivated organism. To investigate the basis for such a difference, we studied immune responses in BALB/c mice immunized with viable or UV-killed C. trachomatis mouse pneumonitis (MoPn). Strong, acquired resistance to C. trachomatis infection was elicited by immunization with viable but not dead organisms. Immunization with viable organisms induced high levels of antigen-specific delayed-type hypersensitivity (DTH), gamma interferon production, and immunoglobulin A (IgA) responses. Immunization with inactivated MoPn mainly induced interleukin-10 (IL-10) production and IgG1 antibody without IgA or DTH responses. Analysis of local early cytokine and cellular events at days 3, 5, and 7 after peritoneal cavity immunization showed that high levels of granulocyte-macrophage colony-stimulating factor and IL-12 were detected with viable but not inactivated organisms. Furthermore, enrichment of a dendritic cell (DC)-like population was detected in the peritoneal cavity only among mice immunized with viable organisms. The results suggest that early differences in inducing proinflammatory cytokines and activation and differentiation of DCs may be the key mechanism underlying the difference between viable and inactivated organisms in inducing active immunity to C. trachomatis infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084993      PMCID: PMC96503          DOI: 10.1128/IAI.67.4.1606-1613.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Langerhans cells and T lymphocyte subsets in the murine vagina and cervix.

Authors:  M B Parr; E L Parr
Journal:  Biol Reprod       Date:  1991-03       Impact factor: 4.285

2.  Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells.

Authors:  D M Ojcius; Y Bravo de Alba; J M Kanellopoulos; R A Hawkins; K A Kelly; R G Rank; A Dautry-Varsat
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

Review 3.  The relationship of delayed hypersensitivity to acquired cellular resistance.

Authors:  G B Mackaness
Journal:  Br Med Bull       Date:  1967-01       Impact factor: 4.291

4.  Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.

Authors:  T W Cotter; K H Ramsey; G S Miranpuri; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Epidemiology of ocular chlamydial infection in a trachoma-hyperendemic area.

Authors:  S K West; P Rapoza; B Muñoz; S Katala; H R Taylor
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

6.  Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines.

Authors:  K H Ramsey; R G Rank
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

7.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection.

Authors:  X Yang; K T HayGlass; R C Brunham
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

8.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.

Authors:  J U Igietseme; D M Magee; D M Williams; R G Rank
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

10.  Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells.

Authors:  S Constant; C Pfeiffer; A Woodard; T Pasqualini; K Bottomly
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

View more
  16 in total

1.  Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.

Authors:  Chunxue Lu; Hao Zeng; Zhihong Li; Lei Lei; I-Tien Yeh; Yimou Wu; Guangming Zhong
Journal:  Vaccine       Date:  2011-11-10       Impact factor: 3.641

2.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

3.  Fate of Mycobacterium tuberculosis within murine dendritic cells.

Authors:  K A Bodnar; N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells.

Authors:  Hong Yu; Karuna P Karunakaran; Isabelle Kelly; Caixia Shen; Xiaozhou Jiang; Leonard J Foster; Robert C Brunham
Journal:  J Immunol       Date:  2011-02-04       Impact factor: 5.422

5.  Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.

Authors:  Z Dong-Ji; X Yang; C Shen; H Lu; A Murdin; R C Brunham
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Comparative evaluation of the protective efficacy of two formulations of a recombinant Chlamydia abortus subunit candidate vaccine in a mouse model.

Authors:  Qing Pan; Roshan Pais; Adaugo Ohandjo; Cheng He; Qing He; Yusuf Omosun; J U Igietseme; F O Eko
Journal:  Vaccine       Date:  2015-02-17       Impact factor: 3.641

7.  Involvement of LEK1 in dendritic cell regulation of T cell immunity against Chlamydia.

Authors:  Qing He; Francis O Eko; Deborah Lyn; Godwin A Ananaba; Claudiu Bandea; Joseph Martinez; Kahaliah Joseph; Kathy Kellar; Carolyn M Black; Joseph U Igietseme
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

8.  Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.

Authors:  Wen Cheng; Pooja Shivshankar; Zhongyu Li; Lili Chen; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

9.  Prostaglandin E2 modulates dendritic cell function during chlamydial genital infection.

Authors:  Wei Liu; Kathleen Ann Kelly
Journal:  Immunology       Date:  2007-08-03       Impact factor: 7.397

10.  A MyD88-dependent early IL-17 production protects mice against airway infection with the obligate intracellular pathogen Chlamydia muridarum.

Authors:  Xiaoyun Zhang; Lifen Gao; Lei Lei; Youmin Zhong; Peter Dube; Michael T Berton; Bernard Arulanandam; Jinshun Zhang; Guangming Zhong
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.